Triplet Repeat Disorders

Triplet Repeat Disorders are genetic disorders that occur as a result of expansion of trinucleotide repeats in certain genes. Examples include Huntington’s disease, certain types of spinocerebellar ataxia, and Fragile X syndrome, among others. Here is the latest research.

October 23, 2020

Predictive testing for neurodegenerative diseases in the age of next-generation sequencing

Journal of Genetic Counseling
Jill GoldmanKaren Marder
October 24, 2020
Review

Peritoneal dialysis patient selection from a comorbidity perspective

Seminars in Dialysis
Eray ErogluBengt Lindholm
October 22, 2020
Preprint
Open Access

Selective role of the translin/trax RNase complex in hippocampal synaptic plasticity

ResearchSquare
Alan Jung ParkTed Abel
October 19, 2020
Open Access

Altered third-party punishment in Huntington's disease: A study using neuroeconomic games

Brain and Behavior
Martin BrüneCarsten Saft
October 23, 2020
Preprint
Open Access

Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability

ResearchSquare
Carol L Wilkinson, C. A. Nelson
October 22, 2020
Open Access

Geographical accessibility and spatial coverage modelling of public health care network in rural and remote India

PloS One
Veenapani Rajeev Verma, Umakant Dash
October 22, 2020

Interregulation between Fragile X Mental Retardation Protein and Methyl CpG Binding Protein 2 in the Mouse Posterior Cerebral Cortex

Human Molecular Genetics
Jason ArsenaultDavid R Hampson
October 23, 2020
Open Access

The Fragile X Mental Retardation Protein regulates RIP1K and colorectal cancer resistance to necroptosis

Cellular and Molecular Gastroenterology and Hepatology
Antonio Di GraziaIvan Monteleone
October 13, 2020
Preprint
Open Access

Increased aperiodic gamma power in young boys with Fragile X is associated with better language ability

MedRxiv : the Preprint Server for Health Sciences
Carol L Wilkinson, C. A. Nelson
October 24, 2020
Open Access

Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice

Scientific Reports
Patricia CogramMichael Tranfaglia
October 23, 2020

Conservative Treatment of Hemorrhoidal Disease

Reviews on Recent Clinical Trials
Emanuela StrattaMario Trompetto
October 20, 2020
Review

Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases

Cellular and Molecular Neurobiology
Nuraqila Mohd MurshidSuzana Makpol
October 23, 2020
Open Access

DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome

International Journal of Molecular Sciences
Claudine M KraanDavid E Godler
October 23, 2020

Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3

Science Translational Medicine
Mercedes PrudencioLeonard Petrucelli
October 16, 2020
Preprint
Open Access

RTP801 Is A Key Modulator For Motor Learning

BioRxiv : the Preprint Server for Biology
L. Perez-SisquesCristina Malagelada
October 18, 2020

Safety and Efficacy of Omaveloxolone in Friedreich's Ataxia (MOXIe Study)

Annals of Neurology
David R LynchColin J Meyer
October 23, 2020

NF-κB disinhibition contributes to dendrite defects in fly models of neurodegenerative diseases

The Journal of Cell Biology
Myeong Hoon HanSung Bae Lee

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS - Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/triplet-repeat-disorders/8d811bef-05e2-42d6-bb0e-def83e3f5303